Skip to main content

News

By Ryan Liabenow | 01:00 am | January 20, 2014
The growth of generic drugs has been a good news story for payers and pharmaceutical benefit managers (PBMs), but that story may be coming to an end.
By John Hesselmann | 01:00 am | January 20, 2014
Whether it's a partnership, a joint venture or the acquisition of one company by another, consolidation remains a hot issue in the healthcare industry.
By Mary Mosquera | 01:00 am | January 20, 2014
A lot of attention has been paid to the percent of mostly healthy adults age 18 to 34 enrolled in the federal and state health insurance exchanges to date.
By Healthcare Finance Staff | 04:39 pm | January 17, 2014
Connecticut's health insurance exchange is the first to meet its enrollment projections, but officials might be hoping to attract younger Nutmeggers before the 2014 open enrollment period ends.
By Healthcare Finance Staff | 02:53 pm | January 17, 2014
The first insurer to post last year's financial results, UnitedHealth Group saw revenues grow 11 percent but margins slip -- a sign of industry pressures ramping up in the new era of health reform.
By Paul Cerrato | 12:11 pm | January 17, 2014
Businesses have used market research for decades to determine what brand of soap consumers like the most, or which luxury car is the "coolest," but physician leaders and hospital C-suite managers have traditionally shied away from such Madison Avenue tactics. But that may be a mistake.
By Richard Pizzi | 11:34 am | January 17, 2014
Our weekly look at career moves in the healthcare finance sector. This issue highlights promotions, hires and fires for the week ending January 17, 2014.
By Fiona Jensen | 10:37 am | January 17, 2014
Healthcare Finance News talked to Kevin Brennan, Geisinger's executive vice president and CFO, about the advantages the health system has seen by adopting the bundled payment model.
By Kelsey Brimmer | 04:29 pm | January 16, 2014
Empowered consumers, rapid innovation and increasing competition are among PwC's top health industry issues for 2014.
By Healthcare Finance Staff | 03:25 pm | January 16, 2014
After recovering claims from a pharmacy provider, a group of 27 states are suing Novartis, alleging the company participated in a kickback scheme to boost Medicaid sales for a controversial blood drug.